Cholesterol-lowering effect of soy protein in normocholesterolemic and hypercholesterolemic men. 1998

W W Wong, and E O Smith, and J E Stuff, and D L Hachey, and W C Heird, and H J Pownell
US Department of Agriculture/ARS Children's Nutrition Research Center, the Department of Pediatrics, Baylor College of Medicine, Houston 77030, USA. wwong@bcm.tmc.edu

Cardiovascular heart disease is a major health problem in the United States. Elevated blood cholesterol has been shown to significantly increase the risk of cardiovascular heart disease. The National Cholesterol Educational Program (NCEP) Step I diet, which restricts fat and cholesterol intakes, is usually recommended as the initial treatment to lower blood cholesterol. Soy protein has been shown to be hypocholesterolemic, particularly in hypercholesterolemic subjects. However, the hypocholesterolemic effect of soy protein in subjects with a blood total cholesterol concentration <5.17 mmol/L is not clear. To determine whether soy protein could enhance the hypocholesterolemic effect of the NCEP Step I diet, 13 normocholesterolemic and 13 hypercholesterolemic men aged 20-50 y were enrolled in a randomized, 2-part, crossover study. Subjects were fed either an NCEP Step I soy-protein diet or an NCEP Step I animal protein diet for 5 wk. After a washout period of 10-15 wk, the subjects were fed the alternate diet for 5 wk. The hypocholesterolemic effect of soy protein was found to be independent of age, body weight, pretreatment plasma lipid concentrations, and sequence of dietary treatment. Regardless of plasma lipid status, the soy-protein diet was associated with a statistically significant decrease in the plasma concentrations of LDL cholesterol (P = 0.029) as well as the in the ratio of plasma LDL cholesterol to HDL cholesterol (P = 0.005). Our results indicate that soy protein enhances the hypocholesterolemic effect of the NCEP Step I diet in both normocholesterolemic and hypercholesterolemic men.

UI MeSH Term Description Entries
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004032 Diet Regular course of eating and drinking adopted by a person or animal. Diets
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006937 Hypercholesterolemia A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population. Hypercholesteremia,Elevated Cholesterol,High Cholesterol Levels,Cholesterol Level, High,Cholesterol Levels, High,Cholesterol, Elevated,Cholesterols, Elevated,Elevated Cholesterols,High Cholesterol Level,Hypercholesteremias,Hypercholesterolemias,Level, High Cholesterol,Levels, High Cholesterol
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D018592 Cross-Over Studies Studies comparing two or more treatments or interventions in which the subjects or patients, upon completion of the course of one treatment, are switched to another. In the case of two treatments, A and B, half the subjects are randomly allocated to receive these in the order A, B and half to receive them in the order B, A. A criticism of this design is that effects of the first treatment may carry over into the period when the second is given. (Last, A Dictionary of Epidemiology, 2d ed) Cross-Over Design,Cross-Over Trials,Crossover Design,Crossover Studies,Crossover Trials,Cross Over Design,Cross Over Studies,Cross Over Trials,Cross-Over Designs,Cross-Over Study,Crossover Designs,Crossover Study,Design, Cross-Over,Design, Crossover,Designs, Cross-Over,Designs, Crossover,Studies, Cross-Over,Studies, Crossover,Study, Cross-Over,Study, Crossover,Trial, Cross-Over,Trial, Crossover,Trials, Cross-Over,Trials, Crossover
D030262 Soybean Proteins Proteins which are present in or isolated from SOYBEANS. Dietary Soybean Protein,Soy Bean Protein,Soybean Protein,Dietary Soybean Proteins,Soy Bean Proteins,Soy Protein,Soy Proteins,Bean Protein, Soy,Protein, Dietary Soybean,Protein, Soy,Protein, Soy Bean,Protein, Soybean,Proteins, Dietary Soybean,Proteins, Soy,Soybean Protein, Dietary,Soybean Proteins, Dietary

Related Publications

W W Wong, and E O Smith, and J E Stuff, and D L Hachey, and W C Heird, and H J Pownell
December 1997, Journal of the American College of Nutrition,
W W Wong, and E O Smith, and J E Stuff, and D L Hachey, and W C Heird, and H J Pownell
January 2007, Advances in therapy,
W W Wong, and E O Smith, and J E Stuff, and D L Hachey, and W C Heird, and H J Pownell
January 2006, International journal of food sciences and nutrition,
W W Wong, and E O Smith, and J E Stuff, and D L Hachey, and W C Heird, and H J Pownell
February 1988, Archives of internal medicine,
W W Wong, and E O Smith, and J E Stuff, and D L Hachey, and W C Heird, and H J Pownell
February 2001, The American journal of clinical nutrition,
W W Wong, and E O Smith, and J E Stuff, and D L Hachey, and W C Heird, and H J Pownell
September 2004, Nutrition journal,
W W Wong, and E O Smith, and J E Stuff, and D L Hachey, and W C Heird, and H J Pownell
January 2004, The Journal of nutrition,
W W Wong, and E O Smith, and J E Stuff, and D L Hachey, and W C Heird, and H J Pownell
April 1994, Biological psychiatry,
W W Wong, and E O Smith, and J E Stuff, and D L Hachey, and W C Heird, and H J Pownell
January 2012, Oxidative medicine and cellular longevity,
W W Wong, and E O Smith, and J E Stuff, and D L Hachey, and W C Heird, and H J Pownell
May 2006, European journal of pharmacology,
Copied contents to your clipboard!